GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (LTS:0M26) » Definitions » Price-to-Funds-From-Operations

XOMA Royalty (LTS:0M26) Price-to-Funds-From-Operations : (As of Mar. 31, 2025)


View and export this data going back to 2018. Start your Free Trial

What is XOMA Royalty Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


XOMA Royalty Business Description

Industry
Traded in Other Exchanges
Address
2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.